About In Vitro Diagnostics
There are 3.99K companies in the In Vitro Diagnostics sector across the world, with 2.23K funded companies having collectively raised $43.9B in venture capital money and private equity. Overall 957 of these are Series A+ funded and the sector has seen the creation of 7 Unicorns.
In Vitro Diagnostics sector has seen 345 acquisitions and 180 IPOs. This represents almost 13.2% of all such companies - which is higher than the 3.8% exit rate of tech companies in general.
This sector includes companies engaged in R&D for diagnostics tests for diagnosis and treatment of various diseases.
In Vitro Diagnostics sector is also known as In Vitro Diagnostics Solutions, Advanced In Vitro Diagnostics or Digital In Vitro Diagnostics.
Companies included in In Vitro Diagnostics sector
Companies developing assays on samples such as blood or tissue that have been taken from the human body for the diagnosis of various diseases.Companies excluded in In Vitro Diagnostics sector
Traditional Diagnostic Technologies, Diagnostic Devices, In vivo Testing TechnologiesMarket Map of In Vitro Diagnostics
The market map of In Vitro Diagnostics gives a visual overview of the sector, showing key business models, their interactions in the value chain, and industry evolution. Top 3 trending business models in In Vitro Diagnostics sector are Neurological Diagnostics, Veterinary In Vitro Diagnostics and Pan Cancer Analysis Tests.
Reports related to In Vitro Diagnostics
Here are some reports related to In Vitro Diagnostics sector:
Free
In Vitro Diagnostics - Sector Report
Edition: October, 2026 (76 Pages)
Premium
In Vitro Diagnostics Investor Landscape
Edition: March, 2025 (12 Pages)
View all reports related to In Vitro Diagnostics. Sign up today!Top Companies in In Vitro Diagnostics
There are more than 3.99K companies in In Vitro Diagnostics. Guardant Health is the top In Vitro Diagnostics company globally, ranked using Tracxn Score (what's this?).
Here are 5 of the top In Vitro Diagnostics companies globally:
Company | Description | Location | Founded | Current Stage | Private Funding Raised |
|---|---|---|---|---|---|
Developer of digital sequencing technology for cancer detection | Redwood City (United States) | 2012 | Public | $557M | |
Developer of cell-free DNA testing for oncology, women’s health, and organ health | Redwood City (United States) | 2004 | Public | $152M | |
Developer of a screening platform for circulating tumor DNA to detect cancer | Menlo Park (United States) | 2016 | Public | $2B | |
Developer of diagnostics assays for the detection of cancer | Boulder (United States) | 2005 | Public | $200M | |
Developer of point-of-care molecular diagnostic platform for infectious disease detection | Salcete (India) | 2000 | Public | $124M |
Companies founded year-on-year in the In Vitro Diagnostics sector
21 new startups have been founded so far in 2026 in the In Vitro Diagnostics sector. 215 In Vitro Diagnostics startups were founded in 2017 - this is the most number of startups founded in any year in the last 10 years.
- Total Number of Companies
Year | No. of companies |
|---|---|
2026 | 21 |
2025 | 27 |
2024 | 65 |
2023 | 66 |
2022 | 86 |
2021 | 112 |
2020 | 181 |
2019 | 157 |
2018 | 188 |
2017 | 215 |
Companies founded across countries in the In Vitro Diagnostics sector
United States has 1,722 In Vitro Diagnostics startups, the most by any country, followed by United Kingdom which has 285 startups and India which has 197.
- Total Number of Companies
Country | No. of companies |
|---|---|
United States | 1,722 |
United Kingdom | 285 |
India | 197 |
Germany | 178 |
China | 169 |
Canada | 131 |
Israel | 126 |
Sweden | 99 |
France | 95 |
South Korea | 90 |
Stage-wise distribution of the In Vitro Diagnostics sector
Out of the total 3,989 In Vitro Diagnostics companies, 2,226 have secured funding. Among them, 957 have reached Series A or higher, and 717 to Series B or beyond.
Founded - 3,989
Funded - 2,226
Series A+ - 957
Series B+ - 717
Series C+ - 616
Company Stage | No. of companies |
|---|---|
Founded | 3,989 |
Funded | 2,226 |
Series A+ | 957 |
Series B+ | 717 |
Series C+ | 616 |
Want to know more about In Vitro Diagnostics ? Signup and explore Tracxn for free
- 4K+ Total Companies
- $43.9B+ Total Funding
- 2.2K+ Funded Companies
- 175+ IPOs
- 340+ Acquisitions
- 4 Reports
Funding Trends in the In Vitro Diagnostics sector
Total funding year-on-year in the In Vitro Diagnostics sector
The In Vitro Diagnostics sector saw a total funding of more than $29.6B in the last 10 years. The most amount of funding was in 2021 at more than $5.34B. There has been a total funding of $808M in 2026 till date.
- Total Funding
Year | Total Funding |
|---|---|
2026 | $808M |
2025 | $2.35B |
2024 | $1.77B |
2023 | $1.39B |
2022 | $2.46B |
2021 | $5.34B |
2020 | $5.01B |
2019 | $3.52B |
2018 | $3.5B |
2017 | $3.44B |
Total funding across countries in the In Vitro Diagnostics sector
In the last 10 years, In Vitro Diagnostics startups in United States have recieved the highest funding among all countries - $19.9B. China follows with $2.21B and United Kingdom with $780M.
- Total Funding
Country | Total Funding |
|---|---|
United States | $19.9B |
China | $2.21B |
United Kingdom | $780M |
Israel | $463M |
Spain | $411M |
Germany | $220M |
India | $214M |
Sweden | $193M |
Switzerland | $173M |
France | $168M |
Total funding amount raised by stage in the In Vitro Diagnostics sector
Over the last 10 years, the In Vitro Diagnostics sector have seen $699M into Seed Stage funding rounds, $8.45B into Early Stage funding rounds and $9.02B go into Late Stage funding rounds.
Funding Stage | Total Funding |
|---|---|
Late Stage | $9.02B |
Early Stage | $8.45B |
Post IPO | $5.96B |
Grant | $1.66B |
Debt | $755M |
Seed Stage | $699M |
PE | $139M |
Recent Funding Rounds in In Vitro Diagnostics
In the year 2026, till October 2026, In Vitro Diagnostics companies have raised $546M in equity funding across 69 rounds.
In the same period last year (i.e. till October 2025), In Vitro Diagnostics companies had raised $1.04B across 85 rounds.
So, 2026 has seen a 47.37% drop in funding in In Vitro Diagnostics companies as compared to 2025.
Here are some recent, important funding rounds in In Vitro Diagnostics:
Company | Round Raised | Amount Raised | Funding Date | Investors |
|---|---|---|---|---|
Seed | 4454 | Oct 22, 2026 | - | |
Seed | 3320 | Oct 15, 2026 | - | |
Series B | 1149 | Oct 14, 2026 | and 2 more | |
Seed | 3677 | Sep 25, 2026 | ||
Seed | 6932 | Sep 23, 2026 | - |
Top Investors in In Vitro Diagnostics
HHS is the top investor in In Vitro Diagnostics companies based on number of companies invested.
Here are some top investors in In Vitro Diagnostics:
Investor | Location | Top Portfolio Companies |
|---|---|---|
Washington, DC (United States) | ||
Brussels (Belgium) | ||
Arlington (United States) | ||
M&A activity in In Vitro Diagnostics
In the year 2026, till October 2026, 14 acquisitions happened in In Vitro Diagnostics sector. Last year, in 2025, a total of 14 acquisitions happened in In Vitro Diagnostics sector.
Here are some recent, important acquisitions in In Vitro Diagnostics:
Company | Acquisition Type | Acquisition Date | Acquirers |
|---|---|---|---|
Business Acquisition | Oct 19, 2026 | ||
Business Acquisition | Sep 14, 2026 | ||
Business Acquisition | Aug 10, 2026 | ||
Business Acquisition | Jul 20, 2026 | ||
Business Acquisition | Jun 04, 2026 |
Acquisition trends in In Vitro Diagnostics
Here are the acquisition trends in In Vitro Diagnostics:
- Total Number of Acquisitions
Year | No. of companies |
|---|---|
2026 | 14 |
2025 | 14 |
2024 | 11 |
2023 | 16 |
2022 | 23 |
2021 | 32 |
2020 | 23 |
2019 | 20 |
2018 | 23 |
2017 | 24 |
IPOs in In Vitro Diagnostics
In the year 2026, till August 2026, 3 IPOs happened in In Vitro Diagnostics sector.
Here are some recent, important IPOs in In Vitro Diagnostics:
Company | IPO Date | Exchange Symbol |
|---|---|---|
Aug 17, 2026 | Bombay Stock Exchange (BSE), National Stock Exchange (NSE) | |
Feb 19, 2026 | National Association of Securities Dealers Automated Quotations (NASDAQ) | |
Jan 09, 2026 | Hong Kong Exchanges (HKG) | |
Nov 06, 2025 | National Association of Securities Dealers Automated Quotations (NASDAQ) | |
Oct 14, 2025 | Australian Securities Exchange (ASX) |
Colleges which produce the most In Vitro Diagnostics companies
Companies founded by alumni from top colleges in the In Vitro Diagnostics sector
Most number of In Vitro Diagnostics startups have been founded by alumni from Stanford University, Massachusetts Institute of Technology and Harvard University.
College | No. of companies |
|---|---|
Stanford University | 44 |
Massachusetts Institute of Technology | 42 |
Harvard University | 40 |
University of Cambridge | 29 |
University of Oxford | 28 |
University of California (Berkeley) | 19 |
Cornell University | 18 |
Tel Aviv University | 18 |
University of Pennsylvania | 18 |
Harvard Business School | 17 |
Total funding in companies founded by alumni from top colleges in the the In Vitro Diagnostics sector
In the last 10 years, Stanford University graduates' In Vitro Diagnostics companies have raised the most funding among top colleges. University of Oxford alumni are second, and Cornell University alumni are third.
College | Total Funding |
|---|---|
Stanford University | $3.4B |
University of Oxford | $1.99B |
Cornell University | $1.7B |
Massachusetts Institute of Technology | $1.41B |
University College London | $1.35B |
Harvard University | $1.08B |
University of Cambridge | $856M |
Princeton University | $528M |
Duke University | $502M |
University of California (Berkeley) | $486M |
Top News in In Vitro Diagnostics
•
•
The Quantra® System from HemoSonics Earns Best Instrument Honors at 85th Annual AAST MeetingBusiness Wire•Oct 22, 2026•Hemosonics
•
Daxor to Showcase Next-Gen Blood Volume Analyzer and New Clinical Data at HFSA 2026GlobeNewswire•Oct 01, 2026•Daxor
•
•
•
•
•
•
Vortex Selected to Represent the Cambridge x Manchester Partnership at Cambridge Tech Week 2026 Manchester, UKVortex Liquid Biopsy Solutions•Sep 02, 2026•Vortex Biosciences
•
